SC Harvester Papers Database Interface

S815 Patients With Neuro-Developmental Disorders Are Associated With a Higher Risk of Inflammatory Bowel Disease: A Nationwide Population-Based Study

K. A. Alchirazi, Osama Hamid, Abdul Mohammed, R. Nanah, M. Regueiro. In: The American Journal of Gastroenterology. 2022

S88 Immune Checkpoint-Inhibitors Are Associated With a Higher Risk of Cholangitis: A Nationwide Population-Wide Study

K. A. Alchirazi, Osama Hamid, Y. A. Omar, R. Nanah, Joud Arnouk et al. In: The American Journal of Gastroenterology. 2022

Abstract: Introduction: Immune checkpoint-inhibitors (ICIs) improve the survival in certain cancers. However, side e ff ects of ICIs might limit its use. Little is known about their biliary toxicity. Accordingly, we used a large database to investigate the epidemiology of ICI-induced cholangitis and describe underlying associations. Methods: A multi-institutional database (Explorys Inc, Cleveland, OH, USA), ...

S1596 Immune Checkpoint-Inhibitors Are Associated With a Higher Risk of Gastritis: A Nationwide Population-Wide Study

K. A. Alchirazi, Y. A. Omar, R. Nanah, M. Sanaka, P. Thota. In: The American Journal of Gastroenterology. 2022

S666 Proton Pump Inhibitors Are Associated With a Higher Risk of Spontaneous Bacterial Peritonitis Independently of Gastrointestinal Bleeding: A Population-Based Study

Somtochukwu Onwuzo, A. Almomani, Prabhat Kumar, E. Krishtopaytis, Almaza a. Albakri et al. In: The American Journal of Gastroenterology. 2022

Abstract: ff erencebetween Grade 3 (25-50,000/mL) and Grade 2 (50-75,000/mL) (OR 1.75, 0.93-3.29). There was also no di ff erence among severity of thrombocytopenia and bleeding risk when post-biopsy data was isolated. Conclusion: Mostlowriskendoscopicproceduresarelikelysafeintheseverelythrombocytopenicpatient,whenconsideringbleedrisk,andstatisticallysigni fi cantbleedsonlyoccurwithcountslessthan25,000/mL.Diag...

S1257 Smoking Increases the Risk for Cirrhosis and Esophageal Varices Among Patients With Non-Alcoholic Fatty Liver Disease

Eduard Krishtopaytis, Prabhat Kumar, Ashraf Almomani, Somtochukwu Onwuzo, A. Boustany et al. In: The American Journal of Gastroenterology. 2022

Abstract: Eduard Krishtopaytis, MD1, Prabhat Kumar, MD1, Ashraf Almomani, MD1, Somtochukwu Onwuzo, MD1, Antoine Boustany, MD, MPH1, Dana Alshaikh, MD2, Almaza A. Albakri, MD3, Motasem Alkhayyat, MD1, Imad Asaad, MD4, Khaled Alsabbagh Alchirazi, MD5. Cleveland Clinic Foundation, Cleveland, OH; Mutah University, Amman, Al Karak, Jordan; Royal Jordanian Medical Services, Amman, Al Karak, Jordan; Cleveland Clin...

S443 Hypogonadism and Testosterone Replacement Therapy Are Associated with a Higher Risk of GERD in Males: A National Cohort Study

Y. A. Omar, R. Nanah, K. A. Alchirazi, Abdul Mohammed, M. Sanaka et al. In: The American Journal of Gastroenterology. 2022

Abstract: is the between has not been well literature.Precisely, the of on has been con literature. The aim of our study is to determine therisk of GERD and its complications among with hypogonadism and the risk of and its complications with those who with hypogonadism. We Cleveland, OH) includes on...

S1042 Comparison of Colectomy Rates in Biologic Naive Ulcerative Colitis Patients on Ustekinumab and Vedolizumab

K. A. Alchirazi, Ahmed Eltelbany, Osama Hamid, Ernesto S. Robalino Gonzaga, R. Garg et al. In: The American Journal of Gastroenterology. 2022

S964 Impact of Biologics Therapy on the Prevalence of Erectile Dysfunction Among Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Study

K. A. Alchirazi, Osama Hamid, R. Nanah, Abdul Mohammed, M. Regueiro. In: The American Journal of Gastroenterology. 2022

Abstract: Introduction: Erectile dysfunction (ED) is a well-established comorbidity of In fl ammatory bowel disease (IBD). However, the connection between the two diseases remains unclear. Previous studies have suggested that chronic in fl ammation resulting in endothelial dysfunction maybe a contributing factor in the pathology of ED. Biologics have been shown to decrease in fl ammation among IBD patients. Th...

S973 Impact of Obesity on Outcomes of Patients With Inflammatory Bowel Disease: A National Inpatient Sample Analysis

Y. A. Omar, R. Nanah, K. A. Alchirazi, Joud Arnouk, George Khoudari et al. In: The American Journal of Gastroenterology. 2022

Abstract: of ustekinumab and vedolizumab on intestinal resection rates in bio-na¨ ı ve CD patients. Methods: A commercial database (Explorys Inc, Cleveland, OH) was utilized, which included electronic health record data from 26 major integrated US healthcare systems. We identi fi ed bio-na¨ ı ve CD patients. The primary outcome was to examine the association between anti-tumor necrosis factor (anti-TNF) medi...

S214 Clinicopathological Characteristics and Management of High-Grade Immune-Related Colitis

K. A. Alchirazi, Ashraf Almomani, A. Boustany, Abel Joseph, Mohammed El-Dallal et al. In: The American Journal of Gastroenterology. 2022

Abstract: showed higher CMV abundance was associated with significantly decreased survival (p50.04) (Figure). When stratified by age, individuals aged$65 with higher CMV abundance had increased overall mortality risk (HR 1.21; p, 0.001) while no significant association was observed between CMV abundance and survival in those aged #55 (Table). Spearman correlation analysis showed intratumoral CMV signatures ...

S806 Impact of Biologics Therapy on the Prevalence of Pregnancy Complications Among Women With Inflammatory Bowel Disease: A Nationwide Population-Based Study

K. A. Alchirazi, Osama Hamid, George Khoudari, M. Regueiro. In: The American Journal of Gastroenterology. 2022

S914 Impact of Anti-TNF on the Prevalence of Hepatobiliary and Pancreatic Disorders Associated With Inflammatory Bowel Disease: A Population-Based Study

K. A. Alchirazi, Ahmed Eltelbany, R. Nanah, Abdul Mohammed, M. Regueiro. In: The American Journal of Gastroenterology. 2022

Abstract: in are of and about are an important aspect of their are to evaluate the and readability of online information related to contraception...

S1558 Risk of Clostridioides difficile Infection in Patients With Celiac Disease: Insight From a U.S.-Based Population Study

M. Alkhayyat, M. Aggarwal, Andrew M. Ford, K. A. Alchirazi, J. Nasser et al. In: The American Journal of Gastroenterology. 2022

Abstract: Migraine Disorder Occurs More Often in Celiac Disease Patients: A Nationwide Population-Based Cohort Study Andrew Ford, MD1, Manik Aggarwal, MD1, Motasem Alkhayyat, MD1, Almaza A. Albakri, MD2, Abel Joseph, MD1, Claire Jansson-Knodell, MD1, Alberto Rubio Tapia, MD3. Cleveland Clinic Foundation, Cleveland, OH; Royal Jordanian Medical Services, Amman, Al Karak, Jordan; Cleveland Clinic, Cleveland, O...

S3273 A Rare Case of Antiphospholipid Syndrome Presenting With Variceal Bleeding and Ascites Secondary to Portal Vein Thrombosis Without Liver Cirrhosis

Ahmed Eltelbany, R. Nanah, Osama Hamid, S. Trakroo, K. A. Alchirazi et al. In: American Journal of Gastroenterology. 2022

S809 Impact of Biologics Therapy on the Prevalence of Parkinson’s Disease Among Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Study

K. A. Alchirazi, Osama Hamid, Abdul Mohammed, M. Regueiro. In: The American Journal of Gastroenterology. 2022

Abstract: Introduction: In fl ammatory bowel disease(IBD) and Parkinson ’ s disease (PD) are chronic progressive disorders that mainlya ff ect di ff erent organs: the gut and brain,respectively. Increasing evidence supports reciprocalcommunication betweenthe enteric and thecentral nervous system in disease, termed the ’ gut-brainaxis ’ . Biologicshave been shownto decrease in fl ammation among IBD patients howe...